We studied safety and clinical efficacy of transplantation of autologous bone marrow cell in complex therapy of 158 patients with chronic hepatitis and cirrhosis of the liver. The efficiency of cell therapy was assessed in 12 months after single injection of the cells. The positive response (alleviation of liver cirrhosis or stabilization of the pathological process) was observed in 70% cases. The efficacy of therapy correlated with the severity and etiology of the disease and was maximum in patients with Child–Pugh class A (in 82.5% cases) and class B liver cirrhosis (in 79% cases); in patients with class C liver cirrhosis, the positive response was achieved in 42.5% cases. In 39 patients, ultrasonic examination performed in 3 years after transplantation revealed no focal lesions or ectopic ossification foci.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
V. V. Burunova, Yu. G. Suzdaltseva, A. V. Voronov, et al., Bull. Exp. Biol. Med., 145, No. 4, 526-530 (2008).
L. B. Lazebnik, O. V. Knyazev, A. G. Konoplyannikov, et al., Geny Kletki, 6, No. 4, 95-103 (2011).
A. A. Ostanin, Ya. L. Petrovskii, E. Ya. Shevela, and E. R. Chernykh, Bull. Exp. Biol. Med., 151, No. 1, 133-141(2011).
E. R. Chernykh, A. A. Ostanin, and A. I. Pal’tsev, Gepatologiya, No. 5, 24-33 (2004).
E. R. Chernykh, A. I. Pal’tsev, and N. M. Starostina, et al., Gepatologiya, No. 1, 30-36 (2005).
E. R. Chernykh, N. M. Starostina, A. I. Pal’tsev, et al., Cell Technologies. Theoretical and Applied Aspects [in Russian], Eds. V. A. Kozlov, et al., Moscow (2009), pp. 171-188.
M. E. Amer, S. Z. El-Sayed, W. A. El-Kheir, et al., Eur. J. Cardiothorac. Hepatol., 23, No. 10, 936-941 (2011).
E. S. Gilchrist and J. N. Plevris, Liver Transl., 16, No. 2, 118-129 (2010).
P. Kharaziha, P. M. Hellström, B. Noorinayer, et al., Eur. J. Cardiothorac. Hepatol., 21, No. 10, 1199-1205 (2009).
J. K. Kim, Y. N. Park, J. S. Kim, et al., Cell Transplant., 19, No. 10, 1237-1246 (2010).
T. Li, Y. Yan, B. Wang, et al., Stem Cells Dev., 22, No. 6, 845-854 (2013).
M. Maumus, C. Jorgensen, and D. Noël, Biochimie, 95, No. 12, 2229-2234 (2013).
M. Mohamadnejad, K. Alimoghaddam, M. Mohyeddin-Bonab, et al., Arch. Iran. Med., 10, No. 4, 459-466 (2007).
L. Peng, D. Y. Xie, B. L. Lin, et al., Hepatology, 54, No. 3, 820-828 (2011).
T. Saito, K. Tomita, H. Haga, et al., World J. Methodol., 3, No. 4, 65-69 (2013).
I. Sakaida, S. Terai, N. Yamamoto, et al., Hepatology, 40, No. 6, 1304-1311 (2004).
N. K. Satija, V. K. Singh, Y. K. Verma, et al., J. Cell Mol. Med., 13, Nos. 11-12, 4385-4402 (2009).
T. Takami, S. Terai, and I. Sakaida, Cur. Opin. Gastroenterol., 28, No. 3, 203-208 (2012).
H. Tsubouchi, S. Kawakami, S. Hirono, et al., Lancet, 340, 307 (1992).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Kletochnye Tekhnologii v Biologii i Meditsine, No. 4, pp. 232-238, October, 2015
Rights and permissions
About this article
Cite this article
Shevela, E.Y., Starostina, N.M., Pal’tsev, A.I. et al. Efficiency of Cell Therapy in Liver Cirrhosis. Bull Exp Biol Med 160, 542–547 (2016). https://doi.org/10.1007/s10517-016-3215-7
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-016-3215-7